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1,25-Dihydroxyvitamin D Exerts Similar
Immunosuppressive Effects as UVR but Is Dispensable
for Local UVR-Induced Immunosuppression
Agatha Schwarz1, Fatemeh Navid1, Tim Sparwasser2, Bjo¨rn E. Clausen3 and Thomas Schwarz1
Low-dose UV radiation (UVR) inhibits the induction of contact hypersensitivity and induces regulatory T cells
(Tregs), which because of their antigen specificity harbor therapeutic potential. Topical application of 1a,25-
dihydroxyvitamin D3 (1,25(OH)2D3) is known to induce Tregs as well, which implies that 1,25(OH)2D3 might be
involved in UVR-induced immunosuppression. It was the aim of this study to clarify this issue, to further
characterize 1,25(OH)2D3-induced Tregs and to determine whether they differ from UVR-induced Tregs. Our
data demonstrate that 1,25(OH)2D3-induced Tregs act in an antigen-specific manner and belong to the Foxp3-
expressing subtype of Tregs as demonstrated by diphtheria toxin (DT)–mediated depletion of Foxp3þ Tregs in
DEREG (depletion of Tregs) mice. Using Langerin-DTR (DT receptor) knock-in mice, it was shown that
Langerhans cells (LCs) are required for the induction of Tregs by 1,25(OH)2D3, as depletion of LCs but not
Langerinþ dermal dendritic cells abrogated the induction of Tregs. Taken together, 1,25(OH)2D3 affects the
immune system in a similar manner as UVR, probably using the same pathways. However, vitamin D receptor
knockout mice were equally susceptible to UVR-induced immunosupppression as wild-type controls. This
indicates that 1,25(OH)2D3 exerts similar immunosuppressive effects as UVR but is dispensable for local UVR-
induced immunosuppression.
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INTRODUCTION
Vitamin D, in particular the biologically active metabolite
1a,25-dihydroxyvitamin D3 (1,25(OH)2D3), is a pleiotropic
hormone exerting a variety of biological effects including the
regulation of bone and mineral metabolism, as well as the
modulation of immune responses. Vitamin D can either be
ingested or is produced in the skin upon UV radiation (UVR).
The active spectrum is within the UVB range (290–320 nm)
and catalyzes the first step of the synthesis. The biologically
active metabolite is then hydroxylated in the liver by one
mitochondrial enzyme (CYP27A1) and five microsomal
enzymes, of which one is CYP2D25, followed by further
hydroxylation in the kidney via CYP27B1 (Zhu and Deluca,
2012). Whether the final hydroxylation can also take place
in the skin is still a matter of debate (Bikle and Pillai, 1993;
Vanhooke et al., 2006).
In the past years, the interest in vitamin D and its analogs as
therapeutic agents has increased. This is because of the fact
that vitamin D deficiency and low 25(OH)D3 levels, respec-
tively, have been suspected—although not undisputed—to
correlate with a variety of pathologic conditions including
multiple sclerosis, allergic asthma, diabetes, and even certain
types of cancer (reviewed in Holick, 2007; Shahriari et al.,
2010; Hart et al., 2011). Moreover, some studies indicated that
vitamin D supplementation reduces the risk of developing
multiple sclerosis and type-I diabetes (reviewed in Fletcher
et al., 2012) or prevents asthma exacerbation triggered by
acute respiratory infection (Majak et al., 2011). Again, these
studies have been criticized for various reasons, and there is
unanimous agreement that further studies are needed.
The fact that the vast majority of diseases that are
supposedly influenced by vitamin D are immune-mediated
is in accordance with the well-known immunosuppressive
effects of vitamin D, which have been proven in numerous
in vitro and in vivo studies (reviewed in Mora et al., 2008).
1,25(OH)2D3 exerts effects on the differentiation of macro-
phages and dendritic cells (DCs), modulates antigen pre-
sentation, enhances the differentiation and activity of
regulatory T cells (Tregs), and reduces T helper 1 and T
helper 17 differentiation, just to name a few (reviewed in Hart
et al., 2011).
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It is firmly established that UVR suppresses the immune
system. One of the hallmark features of UVR-induced
immunosuppression is the induction of Tregs. As UVR-Tregs
act in an antigen-specific manner, they harbor therapeutic
potential (Schwarz, 2008). This idea has been further fostered
by the recent demonstration that UVR-Tregs can be induced
in sensitized mice in vivo and reprogrammed in such a way
that they inhibit the elicitation of contact hypersensitivity
(CHS) and thus act in a therapeutic manner (Schwarz et al.,
2011). However, DNA damage caused by UVR in Langer-
hans cells (LCs) appears to be essential for the induction of
UVR-Tregs (Schwarz et al., 2005). As DNA damage carries
the risk of potential malignant transformation, we are seeking
for alternative methods to induce similar Tregs without the
need for UVR. Topical application of 1,25(OH)2D3 and the
vitamin D analog calcipotriol, respectively, has been
described to induce Tregs in different models (Gorman
et al., 2007; Ghoreishi et al., 2009). Thus, we were interested
to study whether in the model of hapten-mediated CHS
topical 1,25(OH)2D3 can induce Tregs and whether they
differ from UVR-Tregs. In addition, we sought to clarify
whether UVR-induced immunosuppression is mediated via
vitamin D, which is still a matter of debate.
RESULTS
1,25(OH)2D3-induced immunosuppression is mediated via
Foxp3þ Tregs
Topical application of 1,25(OH)2D3 has been described to
inhibit the induction of CHS and to induce Tregs, the
phenotypic characterization of which, however, is still
incomplete. To further characterize 1,25(OH)2D3-induced
Tregs, we used the model of DNFB-mediated CHS.
As described previously (Guo et al., 1992), topical
application of 1,25(OH)2D3 onto naive mice inhibited the
induction of CHS and induced lymphocytes with suppressor
activity, as demonstrated by adoptive transfer experiments
(data not shown). Foxp3 is a key transcription factor in the
development of natural CD4þCD25þ Tregs. When over-
expressed in T cells, Foxp3 promotes a suppressor phenotype
(Fontenot et al., 2003; Hori et al., 2003). Thus, Foxp3
is currently regarded as the most specific marker for Tregs.
Recently, it was shown that UVR-Tregs express Foxp3
(Schwarz et al., 2011).
To clarify whether the same applies for 1,25(OH)2D3-
induced Tregs, we took advantage of DEREG (depletion of
Tregs) mice. These mice express a diphtheria toxin (DT)
receptor–enhanced GFP under control of the foxp3 gene locus
(Lahl et al., 2007). Injection of DT results in the selective
depletion of all Foxp3þ T cells. 1,25(OH)2D3 was topically
applied on 4 consecutive days on the shaved backs of DEREG
mice. At 24hours after the last treatment, animals were
sensitized by painting DNFB onto 1,25(OH)2D3-treated skin.
After another 48hours, DT was injected for 3 consecutive
days. Five days after sensitization, lymph node cells and
splenocytes were obtained and injected into naive wild-type
(WT) mice. After 24hours, the recipients were sensitized
against DNFB and ear challenge was performed 5 days
thereafter. Cells obtained from DEREG mice treated with
1,25(OH)2D3 significantly suppressed CHS in the recipients
(Figure 1, no. 3). In contrast, sensitization was not reduced
upon transfer of cells obtained from DEREG mice treated
with 1,25(OH)2D3 and DT (Figure 1, no. 4). This indicates
that similar to UVR 1,25(OH)2D3 induces Tregs that express
Foxp3.
1,25(OH)2D3-induced Tregs suppress CHS in an antigen-
specific way
One of the main features of UVR-Tregs is the antigen-specific
mode of action (Schwarz, 2008). To address whether the
same applies for 1,25(OH)2D3-induced Tregs, lymph node
cells and splenocytes were obtained from mice painted with
1,25(OH)2D3 and sensitized with DNFB and injected
intravenously into naive recipients, which were subsequently
sensitized against either DNFB or the unrelated hapten
oxazolone (Oxa). Five days later, recipients were challenged
with DNFB or Oxa, respectively. As known from previous
experiments, injection of cells obtained from sensitized mice
does not alter the CHS response and does not induce Tregs in
the recipients. Transferred cells obtained from 1,25(OH)2D3-
treated and DNFB-sensitized donors suppressed in the
recipients the CHS response only against DNFB, but not
against Oxa (Figure 2). This indicates that 1,25(OH)2D3-
induced Tregs act in an antigen-specific manner.
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Figure 1. Induction of immunosuppression by 1a,25-dihydroxyvitamin D3
(1,25(OH)2D3) is mediated via Foxp3
þ regulatory T cells (Tregs). DEREG
(depletion of regulatory T cells) mice were painted on the backs with
1,25(OH)2D3 for 4 consecutive days. At 24hours after the last treatment, mice
were sensitized with DNFB painted onto 1,25(OH)2D3-treated skin. At 48hours
after sensitization, one group of animals received 1mg diphtheria toxin (DT) on
3 consecutive days. Five days after sensitization, splenocytes and lymph node
cells were obtained from 1,25(OH)2D3-treated DEREG mice and injected
intravenously (i.v). into naive wild-type (WT) mice. Recipients were sensitized
against DNFB 24hours after transfer. Five days later, challenge with DNFB was
performed. Positive control (Pos Co) mice were sensitized and challenged,
whereas negative control (Neg Co) mice were only challenged. The ear
swelling response is expressed as the difference (cm103, mean±SD)
between the thickness of the challenged ear and the thickness of the vehicle-
treated ear. *Po0.05 versus Pos Co.
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LCs are required for 1,25(OH)2D3-induced immunosuppression
and induction of Tregs
It was recently shown that LCs are required for UVR-induced
immunosuppression and the induction of UVR-Tregs
(Schwarz et al., 2010). To elucidate the role of LCs in the
development of 1,25(OH)2D3-induced Tregs, we used
Langerin DT receptor (DTR) knock-in (Langerin-DTR) mice
that harbor a targeted insertion of the human DTR into the
Langerin locus (Bennett et al., 2005). Thus, injection
of DT results in depletion of Langerinþ cells. Langerin-DTR
mice were injected with DT and 72 hours later mice were
painted with 1,25(OH)2D3 for 4 days. After 24 hours, animals
were sensitized with DNFB through 1,25(OH)2D3-painted
skin. Langerin-DTR mice that had not received DT behaved
like WT animals. The positive controls responded with a
significant ear swelling response to sensitization. As observed
in WT mice, 1,25(OH)2D3 suppressed the CHS response in
Langerin-DTR mice (Figure 3a, no DT). Animals in which
Langerinþ cells were depleted by DT injection could be
sensitized, although the sensitization response was weaker
than in mice that did not receive DT, confirming previous
observations (Bennett et al., 2005, 2007; Schwarz et al.,
2010). In contrast, topically applied 1,25(OH)2D3 did not
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Figure 2. 1a,25-Dihydroxyvitamin D3 (1,25(OH)2D3)–induced regulatory
T cells (Tregs) act in an antigen-specific manner. (a) C57BL/6 mice were
painted on the backs with 1,25(OH)2D3 for 4 consecutive days (VD3). At
24 hours after the last treatment, mice were sensitized with DNFB painted
onto 1,25(OH)2D3-treated skin. After 5 days, animals were challenged and
ear swelling was measured 24 hours later. *Po0.005 versus Pos Co. (b)
Immediately after measuring ear swelling, splenocytes and lymph node cells
were obtained from 1,25(OH)2D3-treated and DNFB-sensitized donors
depicted in Figure 2a (no. 3, VD) and injected into naive animals. Recipients
were sensitized against DNFB or the irrelevant hapten oxazolone (Oxa)
24 hours after transfer. Five days later, challenge with the respective hapten
was performed. Pos Co mice were sensitized and challenged, whereas
Neg Co were only challenged. *Po0.005 versus Pos Co. Neg Co, negative
control; Pos Co, positive control; VD, vitamin D.
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Figure 3. Langerhans cells are required for 1a,25-dihydroxyvitamin D3
(1,25(OH)2D3)–induced immunosuppression and induction of regulatory
T cells (Tregs). (a) Langerin-diphtheria toxin receptor (DTR) mice were
injected with diphtheria toxin (DT). After 72 hours, mice were painted on the
backs with 1,25(OH)2D3 for 4 consecutive days (VD3). At 24 hours after the
last treatment, mice were sensitized with DNFB painted onto 1,25(OH)2D3-
treated skin. After 5 days, animals were challenged and ear swelling was
measured 24 hours later. Positive controls (Pos Co) comprised DT-treated
Langerin-DTR mice that were sensitized and challenged, whereas negative
controls (Neg Co) comprised those that were only challenged. As additional
controls, Langerin-DTR mice were treated identically but not injected with
DT (No DT). *Po0.005 versus Pos Co, No DT. (b) Immediately after
measuring ear swelling, splenocytes and lymph node cells were obtained
from 1,25(OH)2D3-treated Langerin-DTR mice depicted in Figure 3a (nos 3
and 6). Cells were injected intravenously into naive wild-type (WT) mice
(Transfer). Recipients were sensitized against DNFB 24 hours after injection.
Five days later, challenge with DNFB was performed. Pos Co mice were
sensitized and challenged, whereas Neg Co were only challenged. *Po0.05
versus Pos Co. NS, nonsignificant; VD, vitamin D.
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inhibit sensitization in mice depleted of Langerin-expressing
cells (Figure 3a, DT).
To determine whether 1,25(OH)2D3 induced Tregs, lymph
node cells and splenocytes were obtained from the
1,25(OH)2D3-painted donors (nos 3 and 6 of Figure 3a) and
injected intravenously into naive WT mice. Recipients were
sensitized against DNFB 24hours later. After 5 days, mice
were challenged and ear swelling was evaluated 24hours
later. Mice injected with cells obtained from 1,25(OH)2D3-
painted Langerin-DTR donors that were not treated with DT
were significantly suppressed in their CHS response, indicating
that Tregs had developed in the donors (Figure 3b, no. 3). In
contrast, recipients of cells from Langerin-DTR donors in
which Langerinþ cells were depleted by injection of DT
responded with a significant ear swelling reaction (Figure 3b,
no. 4), suggesting that Tregs did not develop in donors depleted
of Langerinþ cells upon treatment with 1,25(OH)2D3.
Langerin was initially described as a specific marker for
LCs (Takahara et al., 2002). However, shortly thereafter it
turned out that another DC subset located in the dermis also
expresses Langerin (Merad et al., 2008) and is eliminated in
Langerin-DTR mice upon injection of DT (Noordegraaf
et al., 2010). As both LCs and dermal DCs contribute to
inducing sensitization responses through the skin (Romani
et al., 2010), we analyzed their role in 1,25(OH)2D3-induced
immunosuppression and induction of Tregs. To discern
the contribution of LCs and Langerinþ dermal DCs in
this process, Langerin-DTR mice were treated with DT 10
days before 1,25(OH)2D3 application. At this time
point, dermal DCs have repopulated the dermis, whereas
LCs are still absent (Noordegraaf et al., 2010). Animals
were sensitized after treatment with 1,25(OH)2D3 and 5 days
later ear challenge was performed. The ear swelling response
was reduced in mice treated with 1,25(OH)2D3 without
injection of DT when compared with positive controls
(Figure 4a, no. 3). This effect was not observed in
animals injected with DT 10 days before the 1,25(OH)2D3
treatment, indicating that LCs but not dermal DCs are
essential for 1,25(OH)2D3-mediated immunosuppression
(Figure 4a, no. 6).
Adoptive transfer of lymph node cells and splenocytes
obtained from 1,25(OH)2D3-treated but not DT-injected
donors (no. 3 of Figure 4a) into naive WT mice resulted in
a significant reduction of ear swelling, indicating that
Tregs had developed in the donor mice (Figure 4b, no. 3).
In contrast, animals that received cells from donors
treated with DT 10 days before 1,25(OH)2D3 application
were not suppressed in their CHS reaction (Figure 4b, no. 4).
In these donor mice, dermal DCs were still present but LCs
were absent, suggesting that LCs but not dermal DCs are
required for induction of 1,25(OH)2D3-induced Tregs.
UVR suppresses the induction of CHS and induces Tregs in
VDR-KO mice
According to the present findings, 1,25(OH)2D3-induced
Tregs appear to be phenotypically very similar to UVR-Tregs.
This nourishes the speculation that UVR-induced immuno-
suppression could be mediated via vitamin D. To clarify this,
we used vitamin D receptor knockout (VDR-KO) mice that
harbor a deletion of a fragment of genomic DNA encoding
the second zinc finger of the receptor DNA-binding domain
(Li et al., 1997). VDR-KO and WT controls were exposed to
UVR (1.5 kJm2) on 4 consecutive days. At 24 hours after the
last exposure, animals were sensitized with DNFB through
irradiated skin and challenged 5 days later. UVR-exposed WT
mice responded to sensitization with a marginal ear swelling
response, which was comparable to that of negative controls
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Figure 4. Langerinþ dermal dendritic cells (DCs) are not involved in 1a,25-
dihydroxyvitamin D3 (1,25(OH)2D3)–induced immunosuppression and
induction of regulatory T cells (Tregs). (a) Langerin–diphtheria toxin receptor
(DTR) mice were injected with diphtheria toxin (DT). After 10 days, mice
were painted on the backs with 1,25(OH)2D3 for 4 consecutive days (VD3). At
24 hours after the last treatment, mice were sensitized with DNFB painted
onto VD3-treated skin. After 5 days, animals were challenged and ear swelling
was measured 24hours later. Positive controls (Pos Co) comprised DT-treated
Langerin-DTR mice that were sensitized and challenged, whereas negative
controls (Neg Co) were only challenged. As additional controls, Langerin-
DTR mice were treated identically but not injected with DT (No DT).
*Po0.0005 versus Pos Co, No DT. (b) Immediately after measuring ear
swelling, splenocytes and lymph node cells were obtained from
1,25(OH)2D3-treated Langerin-DTR mice depicted in Figure 4a (nos 3 and 6).
Cells were injected intravenously (i.v.) into naive wild-type (WT) mice
(Transfer). Recipients were sensitized against DNFB 24 hours after injection.
Five days later, challenge with DNFB was performed. Pos Co mice were
sensitized and challenged, whereas Neg Co mice were only challenged.
*Po0.0005 versus Pos Co. VD, vitamin D.
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(Figure 5a, no. 3). Sensitized VDR-KO mice reacted with
robust ear swelling upon DNFB challenge, indicating that
these mice can be fully sensitized. Upon UVR exposure, the
CHS reaction was significantly reduced comparable to that of
UVR-exposed WT mice (Figure 5a, no. 6), indicating that
inhibition of the induction of CHS by UVR is independent of
a functional VDR and consequently of receptor-dependent
action of vitamin D.
To determine whether UVR-Tregs developed, lymph
nodes and spleens were obtained from UVR-exposed
WT and VDR-KO mice (nos 3 and 6 of Figure 5a).
Cells were injected intravenously into naive WT mice,
which were sensitized against DNFB 24hours later. Recipi-
ents injected with cells from UVR-exposed WT animals
revealed a significantly attenuated CHS response, indicating
that Tregs had developed in the donors (Figure 5b). A
similar suppression was observed in recipients that received
cells obtained from UV-irradiated VDR-KO mice, implying
that development of UVR-Tregs is not dependent on
vitamin D.
DISCUSSION
Despite the ongoing controversy whether 1,25(OH)2D3 can
be produced entirely in the skin (Bikle and Pillai, 1993;
Vanhooke et al., 2006), we used 1,25(OH)2D3 as most of the
similar studies were conducted with this compound. We also
decided to apply 1,25(OH)2D3 on 4 consecutive days in
analogy to the UVR regimen, as it was our primary intention
not to imitate a physiological process but to identify an
alternative route by which Tregs can be induced. Guo et al.
(1992) were the first to describe the inhibition of CHS by
topically applied 1,25(OH)2D3. On the basis of adoptive
transfer experiments, which showed that suppression can be
transferred at a cellular level into naive recipients, the authors
concluded that suppressor lymphocytes were induced. It took
several years until these cells were further characterized.
Using a different model, Gorman et al. (2007) showed that
1,25(OH)2D3 induces CD4
þFoxp3þ Tregs, which expanded
in vivo in syngeneic recipients upon antigenic stimulation.
Similarly, Ghoreishi et al. (2009) reported that transcutaneous
immunization through calcipotriol-treated skin augments
CD4þCD25þFoxp3þ Treg populations. As Foxp3 is ex-
pressed intracellularly, antibody-mediated depletion studies
are not possible. Hence, the only strategy to prove the
functional involvement of Foxp3-expressing Tregs in vivo is
the utilization of DEREG mice in which Foxp3-expressing
cells can be selectively depleted by the injection of DT (Lahl
et al., 2007). DEREG mice not injected with DT behaved like
WT mice both in terms of sensitization and adoptive transfer
experiments. However, when 1,25(OH)2D3-treated DEREG
mice were injected with DT after sensitization, suppression
was lost upon cell transfer. This clearly indicates on a
functional level that 1,25(OH)2D3-induced cells transferring
suppression express Foxp3 and thus belong to the Foxp3þ
subtype of Tregs. Comparable to UVR-Tregs, they act in an
antigen-specific manner, as 1,25(OH)2D3-induced Tregs
obtained from DNFB-sensitized donors inhibited the sensiti-
zation response only against DNFB but not against Oxa in the
recipients.
Antigen-presenting cells appear to be one of the major
cellular targets for 1,25(OH)2D3 to exert its immunosuppres-
sive features. Guo et al. (1992) were the first to describe a
reduction in the number of LCs upon topical application of
1,25(OH)2D3. The same applies for calcipotriol, as recently
reported by Ghoreishi et al. (2009). As the dendrites of LCs
decreased and the cells became oval or round after topical
administration of 1,25(OH)2D3, Guo et al. (1992) already
speculated that this may be associated with an inhibition of
antigen presentation. According to recent data by Gorman
et al. (2010), 1,25(OH)2D3 appears to induce the emigration
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Figure 5. UV radiation (UVR)-induced immunosuppression and
development of regulatory T cells (Tregs) are not impaired in vitamin D
receptor knockout (VDR-KO) mice. (a) C57BL/6 (wild type, WT) and VDR-
KO mice were UVR exposed (1.5 kJm2) for 4 consecutive days. At 24 hours
after the last UVR exposure, mice were sensitized with DNFB painted onto
UV-irradiated skin. After 5 days, animals were challenged and ear swelling
was measured 24hours later. Positive control (Pos Co) mice were sensitized
and challenged, whereas negative controls (Neg Co) were only challenged.
*Po0.0005 versus Pos Co WT; **Po0.0005 versus Pos Co VDR-KO. (b)
Immediately after measurement, splenocytes and lymph node cells were
obtained from UVR-exposed WT and VDR-KO mice (Figure 5a, nos 3 and 6)
and injected intravenously (i.v.) into naive WT mice (Transfer). Recipients
were sensitized against DNFB 24 hours after injection. Five days later,
challenge was performed. *Po0.005 versus Pos Co; **Po0.0005 versus Pos Co.
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of skin-derived DCs into the lymph nodes, where they
alter the function of Tregs residing in the skin-draining
lymph nodes. Indoleamine 2,3-dioxygenase may be involved
in this process.
In their elegant work, Gorman et al. (2010) did not define
the skin-derived DC population affected by topical
1,25(OH)2D3. To get more insight into this, we used
Langerin-DTR mice in which Langerin-expressing cells can
be depleted by DT (Bennett et al., 2007). Using this system,
we previously showed that the primary target cell for UVR to
exert its immunosuppressive features is the LC (Schwarz
et al., 2010). Langerin-depleted mice turned out to be
resistant to 1,25(OH)2D3-induced suppression of the induc-
tion of CHS and did not develop Tregs, as demonstrated by
adoptive transfer experiments. Langerin, however, is not only
expressed by LCs but also by dermal DCs (Bursch et al., 2007;
Ginhoux et al., 2007; Poulin et al., 2007; Nagao et al., 2009).
When 1,25(OH)2D3 was applied topically 10 days after
DT injection, a time point at which LCs were selectively
absent, CHS was not suppressed and Tregs did not develop.
This indicates that LCs but not dermal DCs are the crucial
target cell for 1,25(OH)2D3 to exert its immunosuppressive
features. These data are in accordance with recent in vitro
findings by van der Aar et al. (2011). In this report,
1,25(OH)2D3-primed human LCs induced CD25
hiFoxp3þ
Tregs, whereas 1,25(OH)2D3-primed dermal DCs induced
Foxp3 cells, which expressed IL-10 and thus appeared to
belong to the Tr1 subtype.
The mechanism by which 1,25(OH)2D3 modifies LCs to
induce Tregs still remains to be determined. On the basis of
preliminary data, we know that DCs pretreated with
1,25(OH)2D3 before being hapten coupled lose their capacity
to induce sensitization upon intracutaneous injection into
naive recipients. Furthermore, the expression of major
histocompatibility complex-II and B7-2 is suppressed by
1,25(OH)2D3. Hence, we speculate that 1,25(OH)2D3 similar
to UVR induces Tregs by primarily affecting antigen-present-
ing cells.
The current characterization of 1,25(OH)2D3-induced
Tregs, which is still ongoing, implies that they are similar, if
not identical, to UVR-Tregs. Hence, it was obvious to
speculate at this stage that UVR-induced immunosuppression
might be mediated by vitamin D. This is an ongoing debate
(Hart et al., 2011). The involvement of vitamin D was
supported by the observation that topical treatment of human
skin with the vitamin D analog calcipotriene inhibited
immune responses to a similar extent as UVR (Hanneman
et al., 2006). On the other hand, 1,25(OH)2D3 was reported
to reduce UVR-induced DNA damage (Tre´mezaygues et al.,
2009; Mason et al., 2010), which is supposed to be one of the
major molecular triggers of UVR-induced immunosuppres-
sion. Accordingly, topical 1,25(OH)2D3 reduced systemic
immunosuppression induced by UVR in mice (Dixon et al.,
2007). Damian et al. (2010) added further to this discussion
by showing that topical 1,25(OH)2D3, although protecting
from UVR-induced DNA damage, suppresses cutaneous
immunity in humans. Ghoreishi et al. (2009) proposed
that UVR-induced tolerance is induced via a vitamin D
receptor–dependent mechanism, as VDR-KO mice failed to
increase Foxp3þ Tregs in the draining lymph nodes upon
UVR exposure.
To clarify whether vitamin D is involved in the suppres-
sion of DNFB-mediated CHS by low-dose UVR and
subsequent induction of Tregs, we used VDR-KO mice. In
terms of suppression of CHS and induction of Tregs, they
behaved similar to WT mice, suggesting that local
UVR-induced immunosuppression is not mediated via
vitamin D. There are reservations about the validity of
mice in which the vitamin D metabolism or signaling has
been genetically disrupted, as these animals on the long term
suffer from developmental problems leading to skeletal,
reproductive, and immune system dysfunction (Hart et al.,
2011). For our purposes, we used 6–8-week-old mice.
As the average experiment (induction of CHS and generation
of Treg) lasted maximally for 10 days, the mice were
off the experimental protocol at 10 weeks of age at the
latest. At this age, the VDR-KO did not show immunologic
abnormalities. In addition, the mice were kept under a rescue
diet. As they responded equally well to sensitization as
WT mice, obvious major alterations in the immune system
can be excluded.
Taken together, the present data demonstrate that topically
applied 1,25(OH)2D3 acts in a similar manner as UVR in
terms of suppressing the induction of CHS and generating
Tregs. On the other hand, vitamin D does not appear to be
essentially involved in mediating local UVR-induced im-
munosuppression in mice. Independently of this, topical
application of 1,25(OH)2D3 may represent a valid therapeu-
tic strategy to evoke UVR-like immunosuppressive effects
without the need of UVR exposure and its inherent risk of
DNA damage.
MATERIALS AND METHODS
Mice and reagents
Six- to eight-week-old female C57BL/6 mice were purchased from
Charles River Laboratories (Sulzfeld, Germany). Langerin-DTR mice
were previously described (Bennett et al., 2005). To deplete
Langerinþ cells, mice were injected with DT (Merck, Darmstadt,
Germany) intraperitoneally and subcutaneously (400 ng). DEREG
mice were kindly provided by T Sparwasser (Lahl et al., 2007).
VDR-KO mice (B6.129S4-Vdrtm1Mbd/J) were purchased from
Jackson Laboratory (Bar Harbor, ME) and raised from weaning on
2% calcium, 1.25% phosphorus, and 20% lactose rescue diets (Song
et al., 2003). All mice were bred and kept in the central animal
facilities of the University Clinics Schleswig-Holstein, Campus Kiel.
Animal care was provided by expert personnel in compliance with
the relevant laws and institutional guidelines.
1,25(OH)2D3-induced immunosuppression
1,25(OH)2D3 (Sigma-Aldrich, Taufkirchen, Germany) was diluted in
dimethylsulfoxid (100mgml1; Roth, Karlsruhe, Germany) and then
in acetone/olive oil (4:1; 1mgml1). A volume of 100ml was applied
on the shaved back for 4 days. Mice were sensitized with 50 ml of
DNFB (Sigma-Aldrich) solution (0.5% in acetone/olive oil, 4:1) on
the back 24 hours after the last application. Five days later, ears were
challenged with 20ml of 0.3% DNFB. Topical application of the
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vehicle alone did not affect sensitization and did not induce
Tregs. Positive control mice were sensitized and challenged,
whereas negative control mice were only challenged. CHS was
determined as the amount of swelling of the hapten-challenged ear
compared with the thickness of the vehicle-treated ear and expressed
in cm 103. Bars show mean±SD of increase in ear thickness.
UVR-induced immunosuppression
Mice were irradiated on their shaved backs with 1.5 kJm2 UVR on
4 consecutive days. UV irradiation was performed using fluore-
scent bulbs (TL12, Philips, Eindhoven, The Netherlands), which
emit most of their energy within the UVB range (290–320 nm).
At 24 hours after the last UVR exposure, mice were sensitized against
DNFB.
Adoptive transfer
For adoptive transfer, cells were obtained from lymph nodes (axillary
and inguinal) and spleens (ratio 1:5), as described previously (Maeda
et al., 2008). Cells (5 107) were injected intravenously into naive
mice. Recipients were sensitized 24hours after injection and ear
challenge performed 5 days later.
Statistics
Data were analyzed by Student’s t-test. Differences were considered
significant at Po0.05. Unless otherwise stated, one representative of
three independently performed experiments is shown. Each group
contained at least six mice.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We are grateful to Chris Opitz and Graziella Podda for excellent technical
assistance and Arne Voss for help in preparing the graphs. This study was
supported by grants from the German Research Foundation (SCHW625/4-1,
SCHW625/6-1) and The Netherlands Organization for Scientific Research
(NWO, VIDI 917-76-365 to BEC).
REFERENCES
Bennett CL, Noordegraaf M, Martina CA et al. (2007) Langerhans cells are
required for efficient presentation of topically applied hapten to T cells.
J Immunol 179:6830–5
Bennett CL, van Rijn E, Jung S et al. (2005) Inducible ablation of mouse
Langerhans cells diminishes but fails to abrogate contact hypersensitiv-
ity. J Cell Biol 169:569–76
Bikle DD, Pillai S (1993) Vitamin D, calcium, and epidermal differentiation.
Endocr Rev 14:3–19
Bursch LS, Wang L, Igyarto B et al. (2007) Identification of a novel population
of Langerin+ dendritic cells. J Exp Med 204:3147–56
Damian DL, Kim YJ, Dixon KM et al. (2010) Topical calcitriol protects from
UV-induced genetic damage but suppresses cutaneous immunity in
humans. Exp Dermatol 19:e23–30
Dixon KM, Deo SS, Norman AW et al. (2007) In vivo relevance for
photoprotection by the vitamin D rapid response pathway. J Steroid
Biochem Mol Biol 103:451–6
Fletcher JM, Basdeo SA, Allen AC et al. (2012) Therapeutic use of vitamin D
and its analogues in autoimmunity. Recent Pat Inflamm Allergy Drug
Discov 6:22–34
Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the
development and function of CD4+CD25+ regulatory T cells. Nat
Immunol 4:330–6
Ghoreishi M, Bach P, Obst J et al. (2009) Expansion of antigen-specific
regulatory T cells with the topical vitamin d analog calcipotriol.
J Immunol 182:6071–8
Ginhoux F, Collin MP, Bogunovic M et al. (2007) Blood-derived dermal
Langerin+ dendritic cells survey the skin in the steady state. J Exp Med
204:3133–46
Gorman S, Judge MA, Hart PH (2010) Topical 1,25-dihydroxyvitamin D3
subverts the priming ability of draining lymph node dendritic cells.
Immunology 131:415–25
Gorman S, Kuritzky LA, Judge MA et al. (2007) Topically applied 1,25-
dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+
cells in the draining lymph nodes. J Immunol 179:6273–83
Guo Z, Okamoto H, Imamura S (1992) The effect of 1,25(OH)2-vitamin D3
on Langerhans cells and contact hypersensitivity in mice. Arch Dermatol
Res 284:368–70
Hanneman KK, Scull HM, Cooper KD et al. (2006) Effect of topical vitamin D
analogue on in vivo contact sensitization. Arch Dermatol 142:1332–4
Hart PH, Gorman S, Finlay-Jones JJ (2011) Modulation of the immune system
by UV radiation: more than just the effects of vitamin D? Nat Rev
Immunol 11:584–96
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–81
Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell
development by the transcription factor Foxp3. Science 299:1057–61
Lahl K, Loddenkemper C, Drouin C et al. (2007) Selective depletion of
Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204:
57–63
Li YC, Pirro AE, Amling M et al. (1997) Targeted ablation of the vitamin D
receptor: an animal model of vitamin D-dependent rickets type II with
alopecia. Proc Natl Acad Sci USA 94:9831–5
Maeda A, Beissert S, Schwarz T et al. (2008) Phenotypic and functional
characterization of ultraviolet radiation-induced regulatory T cells.
J Immunol 180:3065–71
Majak P, Olszowiec-Chlebna M, Smejda K et al. (2011) Vitamin D
supplementation in children may prevent asthma exacerbation triggered
by acute respiratory infection. J Allergy Clin Immunol 127:1294–6
Mason RS, Sequeira VB, Dixon KM et al. (2010) Photoprotection by
1alpha,25-dihydroxyvitamin D and analogs: further studies on mechan-
isms and implications for UV-damage. J Steroid Biochem Mol Biol 121:
164–8
Merad M, Ginhoux F, Collin M (2008) Origin, homeostasis and function of
Langerhans cells and other Langerin-expressing dendritic cells. Nat Rev
Immunol 8:935–47
Mora JR, Iwata M, von Andrian UH (2008) Vitamin effects on the immune
system: vitamins A and D take centre stage. Nat Rev Immunol 8:685–98
Nagao K, Ginhoux F, Leitner WW et al. (2009) Murine epidermal Langerhans
cells and Langerin-expressing dermal dendritic cells are unrelated and
exhibit distinct functions. Proc Natl Acad Sci USA 2106:3312–7
Noordegraaf M, Flacher V, Stoitzner P et al. (2010) Functional redundancy of
Langerhans cells and Langerin+ dermal dendritic cells in contact
hypersensitivity. J Invest Dermatol 130:2752–9
Poulin LF, Henri S, de Bovis B et al. (2007) The dermis contains Langerin+
dendritic cells that develop and function independently of epidermal
Langerhans cells. J Exp Med 204:3119–31
Romani N, Clausen BE, Stoitzner P (2010) Langerhans cells and more:
Langerin-expressing dendritic cell subsets in the skin. Immunol Rev 234:
120–41
Schwarz A, Maeda A, Kernebeck K et al. (2005) Prevention of UV radiation-
induced immunosuppression by IL-12 is dependent on DNA repair. J Exp
Med 201:173–9
Schwarz A, Navid F, Sparwasser T et al. (2011) In vivo reprogramming of
ultraviolet radiation-induced regulatory T cell migration to inhibit the
elicitation of contact hypersensitivity. J Allergy Clin Immunol 128:
826–33
Schwarz A, Noordegraaf M, Maeda A et al. (2010) Langerhans cells are
required for UVR-induced immunosuppression. J Invest Dermatol 130:
1419–27
2768 Journal of Investigative Dermatology (2012), Volume 132
A Schwarz et al.
Vitamin D and UVR-Induced Immunosuppression
Schwarz T (2008) 25 years of UV-induced immunosuppression mediated by
T cells-from disregarded T suppressor cells to highly respected regulatory
T cells. Photochem Photobiol 84:10–8
Shahriari M, Kerr PE, Slade K et al. (2010) Vitamin D and the skin. Clin
Dermatol 28:663–8
Song Y, Kato S, Fleet JC (2003) Vitamin D receptor (VDR) knockout mice
reveal VDR-independent regulation of intestinal calcium absorption and
ECaC2 and calbindin D9k mRNA. J Nutr 133:374–80
Takahara K, Omatsu Y, Yashima Y et al. (2002) Identification and expression
of mouse Langerin (CD207) in dendritic cells. Int Immunol 14:433–44
Tre´mezaygues L, Seifert M, Tilgen W et al. (2009) 1,25-dihydroxyvitamin D(3)
protects human keratinocytes against UV-B-induced damage: in vitro
analysis of cell viability/proliferation, DNA-damage and -repair.
Dermatoendocrinol 1:239–45
van der Aar AM, Sibiryak DS, Bakdash G et al. (2011) Vitamin D3 targets
epidermal and dermal dendritic cells for induction of distinct regulatory
T cells. J Allergy Clin Immunol 127:1532–40
Vanhooke JL, Prahl JM, Kimmel-Jehan C et al. (2006) CYP27B1 null mice
with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-
hydroxylase promoter activity in the skin. Proc Natl Acad Sci USA
103:75–80
Zhu J, Deluca HF (2012) Vitamin D 25-hydroxylase—four decades of
searching, are we there yet? Arch Biochem Biophys 523:30–6
www.jidonline.org 2769
A Schwarz et al.
Vitamin D and UVR-Induced Immunosuppression
